Mia's Feed
Medical News & Research

Gambia Reports First Confirmed Mpox Case Amid Regional Rise

Gambia Reports First Confirmed Mpox Case Amid Regional Rise

Share this article

The Gambia has confirmed its first mpox case, adding to regional concerns as neighboring countries face rising infection rates. Public health measures are underway to contain the outbreak.

2 min read

On July 23, 2025, The Gambia announced the detection of its first mpox case, signaling the start of an outbreak in the country. The case was identified through routine surveillance, with the patient confirmed on the preceding Friday. This development comes at a time when several neighboring nations in West Africa are experiencing a surge in mpox infections.

Mpox, caused by a virus related to smallpox, is a zoonotic disease that can be transmitted to humans from infected animals, but human-to-human transmission through close contact is also common. The symptoms include fever, muscle aches, and large skin lesions similar to boils, which can sometimes lead to severe health outcomes.

The World Health Organization has classified mpox as an ongoing international health emergency due to its recent increase in cases across West Africa. In response to the new case, the Gambia's Ministry of Health has launched contact tracing, enhanced community engagement, and other measures to prevent further spread.

Authorities are currently conducting genetic sequencing to determine the specific subtype of the virus involved in the outbreak. Historically, neighboring countries such as Sierra Leone, Liberia, and Guinea have reported hundreds to thousands of cases this year, with Sierra Leone reporting over 3,300 cases and Guinea exceeding 200 since September last year. Cases have also been documented in DRC, Uganda, and Burundi.

This development highlights the importance of vigilant monitoring and swift public health responses to control mpox outbreaks in the region.

Source: https://medicalxpress.com/news/2025-07-gambia-declares-mpox-outbreak.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Combining Therapies to Overcome Treatment Resistance in Aggressive Breast Cancer

New research highlights a combination therapy approach that could prevent metastasis and overcome treatment resistance in aggressive triple-negative breast cancer, paving the way for advanced clinical trials.

Australian School-Based Program Significantly Cuts Teen Vaping Rates by 65%

A pioneering school-based vaping prevention program in Australia has reduced teenage vaping by 65%, emphasizing the importance of interactive education in youth health initiatives.

Innovative Drug Targets Mitochondria to Stop Head and Neck Cancers

A groundbreaking drug candidate, LCL768, targets cancer cell mitochondria to induce death in head and neck tumors, offering a promising, targeted alternative to traditional treatments. Currently in preclinical stages, this approach harnesses mitochondrial damage and metabolic disruption to combat resistant cancers.

Australia's Leading Pharmaceutical Companies Urged to Reduce Carbon Emissions

Australian pharmaceutical companies are being called to action to significantly reduce their carbon emissions and embrace sustainable practices to combat climate change and meet regulatory standards.